These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32064627)

  • 21. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate.
    Aguilar AJ
    Acta Ophthalmol Scand Suppl; 2000; (230):52-5. PubMed ID: 11057352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model.
    Crampton HJ
    Clin Ther; 2002 Nov; 24(11):1800-8. PubMed ID: 12501875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
    Abelson MB; Chapin MJ; Kapik BM; Shams NB
    Arch Ophthalmol; 2003 May; 121(5):626-30. PubMed ID: 12742839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparative study of the ocular tolerance after administration of anti-allergic eye drops with or without a preservative].
    Beden C; Helleboid L; Marmouz F; Liard F
    Therapie; 2004; 59(2):259-64. PubMed ID: 15359624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model.
    Greiner JV; Minno G
    Clin Ther; 2003 Jul; 25(7):1988-2005. PubMed ID: 12946546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%.
    Artal MN; Luna JD; Discepola M
    Acta Ophthalmol Scand Suppl; 2000; (230):64-5. PubMed ID: 11057355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allergic contact dermatitis due to eye drops. Their clinical features and the patch test results].
    Aoki J
    Nihon Ika Daigaku Zasshi; 1997 Jun; 64(3):232-7. PubMed ID: 9217366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
    Figus M; Fogagnolo P; Lazzeri S; Capizzi F; Romagnoli M; Canovetti A; Iester M; Ferreras A; Rossetti L; Nardi M
    Eur J Ophthalmol; 2010; 20(5):811-8. PubMed ID: 20383847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.
    Akhavan A; Karimi-Sari H; Khosravi MH; Arefzadeh E; Yavarahmadi M
    Int Forum Allergy Rhinol; 2015 May; 5(5):386-91. PubMed ID: 25678217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thimerosal: a hidden allergen in ophthalmology.
    Tosti A; Tosti G
    Contact Dermatitis; 1988 May; 18(5):268-73. PubMed ID: 3416589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
    D'Arienzo PA; Leonardi A; Bensch G
    Clin Ther; 2002 Mar; 24(3):409-16. PubMed ID: 11952024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic contact dermatitis due to dorzolamide eyedrops.
    Shimada M; Higaki Y; Kawashima M
    Contact Dermatitis; 2001 Jul; 45(1):52. PubMed ID: 11422277
    [No Abstract]   [Full Text] [Related]  

  • 34. Determining initial ocular comfort differences between 0.7% olopatadine and 0.035% ketotifen fumarate.
    Logan A; Pucker AD; Franklin Q; McGwin G; Hogan C; Kelley LR; Christensen M; Brafford R; Lievens C
    Cont Lens Anterior Eye; 2023 Apr; 46(2):101769. PubMed ID: 36195538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketotifen in Over-the-Counter Products Is a Contact Allergen.
    Blackwell W; Cruz P
    Dermatitis; 2020; 31(4):e39-e40. PubMed ID: 32665519
    [No Abstract]   [Full Text] [Related]  

  • 36. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
    Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergic contact dermatitis due to phenylephrine hydrochloride, with an unusual patch test reaction.
    Akita H; Akamatsu H; Matsunaga K
    Contact Dermatitis; 2003 Nov; 49(5):232-5. PubMed ID: 14996044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergic contact blepharoconjunctivitis from dorzolamide.
    Mancuso G; Berdondini RM
    Contact Dermatitis; 2001 Oct; 45(4):243. PubMed ID: 11683843
    [No Abstract]   [Full Text] [Related]  

  • 39. New drugs for allergic conjunctivitis.
    Med Lett Drugs Ther; 2000 May; 42(1077):39-40. PubMed ID: 10825920
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
    Leonardi A; Zafirakis P
    Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.